Andrea Schmidts

3.0k total citations · 3 hit papers
30 papers, 1.8k citations indexed

About

Andrea Schmidts is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Andrea Schmidts has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 14 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in Andrea Schmidts's work include CAR-T cell therapy research (18 papers), Nanowire Synthesis and Applications (7 papers) and CRISPR and Genetic Engineering (5 papers). Andrea Schmidts is often cited by papers focused on CAR-T cell therapy research (18 papers), Nanowire Synthesis and Applications (7 papers) and CRISPR and Genetic Engineering (5 papers). Andrea Schmidts collaborates with scholars based in United States, Germany and Denmark. Andrea Schmidts's co-authors include Marcela V. Maus, Irene Scarfò, Amanda A. Bouffard, Rebecca C. Larson, Mark B. Leick, Stefanie R. Bailey, Ana P. Castaño, Matthew J. Frigault, Bryan D. Choi and Bob S. Carter and has published in prestigious journals such as Nature, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Andrea Schmidts

29 papers receiving 1.8k citations

Hit Papers

CAR-T cells secreting BiTEs circumvent antigen escape wit... 2019 2026 2021 2023 2019 2022 2021 100 200 300 400

Peers

Andrea Schmidts
Irene Scarfò United States
Selene Nuñez-Cruz United States
Elena Sotillo United States
Valentina Hoyos United States
Amer Najjar United States
Haiying Qin United States
Dongrui Wang United States
Amanda A. Bouffard United States
Andrea Schmidts
Citations per year, relative to Andrea Schmidts Andrea Schmidts (= 1×) peers Ignazio Caruana

Countries citing papers authored by Andrea Schmidts

Since Specialization
Citations

This map shows the geographic impact of Andrea Schmidts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Schmidts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Schmidts more than expected).

Fields of papers citing papers by Andrea Schmidts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Schmidts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Schmidts. The network helps show where Andrea Schmidts may publish in the future.

Co-authorship network of co-authors of Andrea Schmidts

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Schmidts. A scholar is included among the top collaborators of Andrea Schmidts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Schmidts. Andrea Schmidts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Larson, Rebecca C., Michael C. Kann, Charlotte Graham, et al.. (2023). Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma. Nature Communications. 14(1). 7509–7509. 23 indexed citations
2.
Larson, Rebecca C., Michael C. Kann, Stefanie R. Bailey, et al.. (2022). CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours. Nature. 604(7906). 563–570. 225 indexed citations breakdown →
3.
Leick, Mark B., Harrison Silva, Irene Scarfò, et al.. (2022). Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia. Cancer Cell. 40(5). 494–508.e5. 88 indexed citations
4.
Jan, Max, Irene Scarfò, Rebecca C. Larson, et al.. (2021). Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide. Science Translational Medicine. 13(575). 180 indexed citations
5.
Schmidts, Andrea, Amanda A. Bouffard, Angela C. Boroughs, et al.. (2020). Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources. Journal for ImmunoTherapy of Cancer. 8(2). e000990–e000990. 18 indexed citations
6.
Larson, Rebecca C., Ana P. Castaño, Amanda A. Bouffard, et al.. (2020). Bispecific CAR T cells for multiple myeloma: natural ligand compared to tandem scFv design. The Journal of Immunology. 204(1_Supplement). 246.3–246.3. 3 indexed citations
7.
Schmidts, Andrea, Maria Ormhøj, Bryan D. Choi, et al.. (2019). Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma. Blood Advances. 3(21). 3248–3260. 85 indexed citations
8.
Choi, Bryan D., Xiaoling Yu, Ana P. Castaño, et al.. (2019). CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity. Nature Biotechnology. 37(9). 1049–1058. 426 indexed citations breakdown →
9.
Choi, Bryan D., Xiaoling Yu, Ana P. Castaño, et al.. (2019). CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. Journal for ImmunoTherapy of Cancer. 7(1). 304–304. 228 indexed citations
10.
Wang, Xiao, Irene Scarfò, Andrea Schmidts, et al.. (2019). Dynamic Profiling of Antitumor Activity of CAR T Cells Using Micropatterned Tumor Arrays. Advanced Science. 6(23). 1901829–1901829. 23 indexed citations
11.
Leick, Mark B., Irene Scarfò, Bryan D. Choi, et al.. (2019). Use of CD70 Targeted Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Acute Myeloid Leukemia (AML). Blood. 134(Supplement_1). 4443–4443. 7 indexed citations
12.
Schmidts, Andrea, Maria Ormhøj, Allison Taylor, et al.. (2018). Engineering an Optimized Trimeric APRIL-Based CAR to Broaden Targetability of Multiple Myeloma. Blood. 132(Supplement 1). 2059–2059. 6 indexed citations
13.
Schmidts, Andrea & Marcela V. Maus. (2018). Making CAR T Cells a Solid Option for Solid Tumors. Frontiers in Immunology. 9. 2593–2593. 154 indexed citations
14.
Schmidts, Andrea, Julian Grünewald, Martina Kleber, et al.. (2018). GFR estimation in lenalidomide treatment of multiple myeloma patients: a prospective cohort study. Clinical and Experimental Nephrology. 23(2). 199–206.
15.
Kreutmair, Stefanie, Andrea Schmidts, Gabriele Ihorst, et al.. (2018). APC/CCdh1 regulates the balance between maintenance and differentiation of hematopoietic stem and progenitor cells. Cellular and Molecular Life Sciences. 76(2). 369–380. 5 indexed citations
16.
Wehrle, Julius, Rainer Claus, Heiko Becker, et al.. (2017). The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemia. Experimental Hematology. 55. 76–85.e3. 3 indexed citations
17.
Schmidts, Andrea, Manuel Hein, Dominik Schnerch, et al.. (2016). Suppression of APC/CCdh1 has subtype specific biological effects in acute myeloid leukemia. Oncotarget. 7(30). 48220–48230. 7 indexed citations
18.
Schnerch, Dominik, Andrea Schmidts, Marie Follo, et al.. (2013). BubR1 is frequently repressed in acute myeloid leukemia and its re-expression sensitizes cells to antimitotic therapy. Haematologica. 98(12). 1886–1895. 21 indexed citations
19.
Schmidts, Andrea, et al.. (2012). Dissecting Stem Cell Proliferation and Differentiation in Association with the Central Cell Cycle Regulator APC/CCdh1. Blood. 120(21). 1236–1236. 1 indexed citations
20.
Kreuzer, J., S. Denger, Andrea Schmidts, et al.. (1996). Fibrinogen promotes monocyte adhesion via a protein kinase C dependent mechanism. Journal of Molecular Medicine. 74(3). 161–165. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026